Boston, MANCT05236062Now EnrollingIRB Ready

Graft Vs Host Disease Clinical Trial in Boston, MA

Access cutting-edge graft vs host disease treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Dana-Farber Cancer Institute

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access graft vs host disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related graft vs host disease treatment provided free

Apply for This Boston Location

Check if you qualify for this graft vs host disease clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Graft Vs Host Disease Study in Boston

This study is about determining if an aerobic and resistance exercise intervention is feasible in patients diagnosed with acute or chronic GVHD (Graft-Versus-Host Disease) after having an allogeneic stem cell transplant. The names of the study interventions involved in this study are: * Aerobic and resistance exercise (A+R) - Home-based aerobic and resistance exercise program * Attention control (AC) - Home-based stretching program

Sponsor: Dana-Farber Cancer Institute

Who Can Participate

Inclusion Criteria

Over 18 years old; children under the age of 18 will be excluded due to rarity of disease
Newly diagnosed with acute or chronic GVHD, starting corticosteroids at a dose of .20 mg/kg or greater for the first time since transplant
Received allogeneic stem cell transplant (any conditioning, any donor) at Dana-Farber Cancer Institute
Physician's clearance to participate in moderate-vigorous intensity exercise
Speak English
Currently participate in less than 60 minutes of structured exercise/week
Willing to travel to Dana-Farber Cancer Institute for necessary data collection
Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

Have a plan for hospital admission within the next 13 weeks at the time of recruitment
If patients are not enrolled within 14 days after initial steroid treatment, they will be ineligible
Pre-existing musculoskeletal or cardiorespiratory conditions
Patients should not have any uncontrolled illness including ongoing or active infection, uncontrolled diabetes, hypertension, or thyroid disease
Patients may not be receiving any other investigational agents, or concurrent biological, chemotherapy, or radiation therapy
Patients with other active malignancies
Participate in more than 60 minutes of structured exercise/week
Unable to travel to Dana-Farber Cancer Institute for necessary data collection
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT05236062) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Graft Vs Host Disease Treatment Options in Boston, MA

If you're searching for graft vs host disease treatment options in Boston, MA, this clinical trial (NCT05236062) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced graft vs host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all graft vs host disease clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in Boston, MA

See all atrial fibrillation clinical trials recruiting in Boston — not just this study.

Browse Atrial Fibrillation Trials in Boston →

Browse More Trials by Condition

Atrial Fibrillation TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA